These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Komaki Y; Komaki F; Micic D; Ido A; Sakuraba A J Clin Gastroenterol; 2019 Jul; 53(6):441-448. PubMed ID: 29672437 [TBL] [Abstract][Full Text] [Related]
23. Review article: bone disease in inflammatory bowel disease. Schulte CM Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():43-9. PubMed ID: 15352893 [TBL] [Abstract][Full Text] [Related]
24. [The risk factor for low bone mineral density in patients with inflammatory bowel disease]. Liu JB; Gao X; Zhang FB; Yang L; Xiao YL; Zhang RD; Li ZP; Hu PJ; Chen MH Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):833-6. PubMed ID: 20079225 [TBL] [Abstract][Full Text] [Related]
25. Risk of diagnosed fractures in children with inflammatory bowel diseases. Kappelman MD; Galanko JA; Porter CQ; Sandler RS Inflamm Bowel Dis; 2011 May; 17(5):1125-30. PubMed ID: 20872833 [TBL] [Abstract][Full Text] [Related]
26. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Gupta G; Lautenbach E; Lewis JD Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1483-90. PubMed ID: 17162240 [TBL] [Abstract][Full Text] [Related]
27. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study. Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567 [TBL] [Abstract][Full Text] [Related]
28. Fracture-associated hospitalizations in patients with inflammatory bowel disease. Ananthakrishnan AN; McGinley EL; Binion DG; Saeian K Dig Dis Sci; 2011 Jan; 56(1):176-82. PubMed ID: 20936351 [TBL] [Abstract][Full Text] [Related]
29. Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC). Pepe J; Zawadynski S; Herrmann FR; Juillerat P; Michetti P; Ferrari-Lacraz S; Belli D; Ratib O; Rizzoli R; Chevalley T; Ferrari SL Inflamm Bowel Dis; 2017 Aug; 23(8):1410-1417. PubMed ID: 28722691 [TBL] [Abstract][Full Text] [Related]
30. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment. Bröms G; Granath F; Stephansson O; Kieler H Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352 [TBL] [Abstract][Full Text] [Related]
31. Risk factors and management of osteoporosis in inflammatory bowel disease. Targownik LE; Bernstein CN; Leslie WD Curr Opin Gastroenterol; 2014 Mar; 30(2):168-74. PubMed ID: 24419292 [TBL] [Abstract][Full Text] [Related]
32. Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease. Veerappan SG; O'Morain CA; Daly JS; Ryan BM Aliment Pharmacol Ther; 2011 Jun; 33(12):1261-72. PubMed ID: 21521250 [TBL] [Abstract][Full Text] [Related]
33. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease. Leung YP; Kaplan GG; Coward S; Tanyingoh D; Kaplan BJ; Johnston DW; Barkema HW; Ghosh S; Panaccione R; Seow CH; ; J Crohns Colitis; 2015 Mar; 9(3):223-30. PubMed ID: 25576754 [TBL] [Abstract][Full Text] [Related]
34. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease. Hilmi I; Sunderesvaran K; Ananda V; Sarji SA; Arumugam K; Goh KL J Clin Endocrinol Metab; 2013 Jun; 98(6):2415-21. PubMed ID: 23553858 [TBL] [Abstract][Full Text] [Related]
35. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Loftus EV; Crowson CS; Sandborn WJ; Tremaine WJ; O'Fallon WM; Melton LJ Gastroenterology; 2002 Aug; 123(2):468-75. PubMed ID: 12145800 [TBL] [Abstract][Full Text] [Related]
36. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Ban L; Tata LJ; Fiaschi L; Card T Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096 [TBL] [Abstract][Full Text] [Related]
37. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease. Krela-Kaźmierczak I; Kaczmarek-Ryś M; Szymczak A; Michalak M; Skrzypczak-Zielińska M; Drwęska-Matelska N; Marcinkowska M; Eder P; Łykowska-Szuber L; Wysocka E; Linke K; Słomski R Calcif Tissue Int; 2016 Dec; 99(6):616-624. PubMed ID: 27639566 [TBL] [Abstract][Full Text] [Related]
38. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients]. Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305 [TBL] [Abstract][Full Text] [Related]
39. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia. Ko Y; Kariyawasam V; Karnib M; Butcher R; Samuel D; Alrubaie A; Rahme N; McDonald C; Cowlishaw J; Katelaris P; Barr G; Jones B; Connor S; Paven G; Chapman G; Park G; Gearry R; Leong RW; Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1453-63.e1. PubMed ID: 25771246 [TBL] [Abstract][Full Text] [Related]
40. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association]. von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]